TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 58th American Society of Hematology Annual Meeting

Go back to TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 58th American Society of Hematology Annual Meeting

TG Therapeutics (TGTX) Misses Q3 EPS by 19c

November 7, 2016 7:34 AM EST

TG Therapeutics (NASDAQ: TGTX) reported Q3 EPS of ($0.50), $0.19 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $38.1 thousand versus the consensus estimate of $30 thousand.

Cash, cash equivalents, investment securities, and interest receivable were $60.7 million as of September 30, 2016.

For... More